Q2 2014

Source filing unavailable

Q2 2014 · —

Revenue—

Net Income

-$23.22M

N/M vs Q2 2013

EPS Diluted

-$0.59

N/M vs Q2 2013

Operating Income-$22,816,000N/M

Operating Cash Flowderived-$17,930,000N/M

Free Cash Flowderived

Same quarter

Metric	Q2 2014	Q2 2013	Q2 2012	Q2 2011
Revenue	—	$11.50M	$0.00	$978.00K
Net Income	-$23.22M	-$8.85M	-$9.70M	-$10.02M
EPS Diluted	-$0.59	-$0.28	-$0.39	-$0.40

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR